Kymera Therapeutics Inc (KYMR) — Cash Flow Reinvestment Rate
Kymera Therapeutics Inc (KYMR) has a Cash Flow Reinvestment Rate of 3.80x as of December 2023, reinvesting $30.58 Million (capex $11.62 Million plus investments $18.95 Million) from operating cash flow of $8.04 Million. Explore capital reinvestment ratio of Kymera Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kymera Therapeutics Inc Cash Flow Reinvestment Rate (2019–2020)
Historical reinvestment intensity for Kymera Therapeutics Inc across 2 annual periods. Also explore total assets of Kymera Therapeutics Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Kymera Therapeutics Inc (2019–2020)
Year-by-year capital reinvestment analysis for Kymera Therapeutics Inc. For live market cap and broader valuation context, see Kymera Therapeutics Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 4.90x | $431.68 Million | $88.13 Million | $9.10 Million | ▲ +432.0% |
| 2019 | 0.92x | $16.49 Million | $17.91 Million | $532.00K | — |